Translational Development Acquisition Corp. (TDAC) |
| 10.82 -0.03 (-0.28%) 10-30 16:00 |
| Open: | 10.82 |
| High: | 10.86 |
| Low: | 10.81 |
| Volume: | 18,211 |
| Market Cap: | 266(M) |
| PE Ratio: | 42.67 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Shell Companies |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 12.73 |
| Resistance 1: | 10.90 |
| Pivot price: | 10.83 |
| Support 1: | 10.84 |
| Support 2: | 10.80 |
| 52w High: | 10.95 |
| 52w Low: | 10.41 |
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Financials
| EPS | 0.260 |
| Book Value | -0.400 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -0.5 |
| Return on Equity (ttm) | 0.0 |
Company news
Sat, 24 Oct 2026
Translational Development Acquisition Corp. Estimates – NASDAQ:TDAC - TradingView
Thu, 08 Oct 2026
Form 4 Translational Development Acquisition Corp For: 8 October By Investing.com - Investing.com UK
Thu, 10 Sep 2026
ProLogium Secures $50M for TDAC Merger - iGrow News
Wed, 19 Aug 2026
Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC - Business Wire
Sat, 01 Aug 2026
ProLogium And Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment - Pulse 2.0
Mon, 06 Jul 2026
TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
